After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Gossamer Bio Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $1.22 and fluctuated between $1.3000 as its day high and $1.1400 as its day low. The current market capitalization of Gossamer Bio Inc is $275.00M. A total of 2.66 million shares were traded on the day, compared to an average of 1.37M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, GOSS has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 11 BUYs and 4 SELLs from insiders. Insiders purchased 1,841,772 shares during that period but sold 22,970.
In the most recent transaction, Milligan Sandra bought 32,000 shares of GOSS for 0.79 per share on Nov 15. After the transaction, the Director now owns 32,000 company shares. In a previous transaction on Nov 13, Giraudo Bryan bought 200,000 shares at 0.56 per share. GOSS shares that COO/CFO owns now total 380,010.
Among the insiders who sold shares, Aranda Richard disposed of 1,814 shares on Jun 22 at a per-share price of $1.29. This resulted in the Chief Medical Officer holding 197,574 shares of GOSS after the transaction. In another insider transaction, Giraudo Bryan bought 55,000 shares at $1.02 per share on Apr 04. Company shares held by the COO/CFO now total 125,990.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for GOSS in the last 3 months, the mean price target is $6.09 with high estimates of $15.00 and low estimates of $0.50. In terms of 52-week highs and lows, GOSS has a high of $2.25 and a low of $0.45.
As of this writing, GOSS has an earnings estimate of -$0.21 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.17 per share and a lower estimate of -$0.29. The company reported an EPS of -$0.45 in the last quarter, which was 8.20% higher than expectations of -$0.49.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. GOSS’s latest balance sheet shows that the firm has $325.22M in Cash & Short Term Investments as of fiscal 2021. There were $185.24M in debt and $39.86M in liabilities at the time. Its Book Value Per Share was $0.46, while its Total Shareholder’s Equity was $121.46M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GOSS is Buy with a score of 4.33.
